Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC] - N0000191544

Pharmacologic Class Information

Pharmacologic Code N0000191544
Pharmacologic Name Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker
Pharmacologic Uses
  • hyperpolarization-activated cyclic nucleotide-gated channel blocker
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
55513-800Corlanor Non-Proprietary Name: IvabradineTablet, Film CoatedOralAmgen IncACTIVE
55513-810Corlanor Non-Proprietary Name: IvabradineTablet, Film CoatedOralAmgen IncACTIVE
55513-813Corlanor Non-Proprietary Name: IvabradineSolutionOralAmgen IncACTIVE